Information Provided By: 
Fly News Breaks for February 11, 2016
GHDX
Feb 11, 2016 | 07:55 EDT
Cowen noted Genomic Health reported in-line Q4 results, but said with the recent price depreciation the shares are increasingly attractive and remain a top pick. Cowen reiterated its Outperform rating and $40 price target on Genomic Health.
News For GHDX From the Last 2 Days
There are no results for your query GHDX
